These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 15234020)

  • 21. Characterisation of focal liver lesions with contrast enhanced ultrasonography.
    Dietrich CF
    Eur J Radiol; 2004 Jun; 51 Suppl():S9-17. PubMed ID: 15234021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Contrast enhanced ultrasound in the liver using low mechanical index--what is the difference?].
    Becker D
    Ultraschall Med; 2002 Dec; 23(6):397-402. PubMed ID: 12514757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
    Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
    Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-time harmonic contrast material-specific US of focal liver lesions.
    Catalano O; Nunziata A; Lobianco R; Siani A
    Radiographics; 2005; 25(2):333-49. PubMed ID: 15798053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Focal liver lesions: evaluation with contrast-enhanced ultrasonography.
    Nicolau C; Brú C
    Abdom Imaging; 2004; 29(3):348-59. PubMed ID: 15354344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of contrast enhanced ultrasound in hepatic imaging.
    Dhamija E; Paul SB
    Trop Gastroenterol; 2014; 35(3):141-51. PubMed ID: 26012317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging of the liver.
    Vassiliades VC; Bernardino ME
    Top Magn Reson Imaging; 1990 Jun; 2(3):1-16. PubMed ID: 2161245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Contrast ultrasound imaging in liver disease].
    Tranquart F; Bleuzen A; Correas JM; Kissel A; Tchuenbou J; Vandooren E
    J Radiol; 2003 Dec; 84(12 Pt 2):2025-40. PubMed ID: 14710035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [CT and MRI of the liver: when, what, why?].
    Budjan J; Schoenberg SO; Attenberger UI
    Radiologe; 2017 May; 57(5):366-372. PubMed ID: 28280859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging.
    Takahashi M; Maruyama H; Shimada T; Kamezaki H; Sekimoto T; Kanai F; Yokosuka O
    Eur J Radiol; 2013 Jan; 82(1):75-84. PubMed ID: 23116806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved detection of hepatic metastases of adrenocortical cancer by contrast-enhanced ultrasound.
    Bauditz J; Quinkler M; Beyersdorff D; Wermke W
    Oncol Rep; 2008 May; 19(5):1135-9. PubMed ID: 18425368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasound contrast agents: an overview.
    Cosgrove D
    Eur J Radiol; 2006 Dec; 60(3):324-30. PubMed ID: 16938418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging of benign and malignant focal liver lesions.
    Martin DR; Semelka RC
    Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):785-802, vi-vii. PubMed ID: 11694438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scintigraphy, ultrasound and CT scanning of the liver.
    Taylor KJ; Sullivan D; Simeone J; Rosenfield AT
    Yale J Biol Med; 1977; 50(5):437-55. PubMed ID: 602255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of real-time contrast-enhanced and real-time virtual sonography in the assessment of malignant liver lesions.
    Sandulescu L; Saftoiu A; Dumitrescu D; Ciurea T
    J Gastrointestin Liver Dis; 2009 Mar; 18(1):103-8. PubMed ID: 19337645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hepatic focal lesions: role of color Doppler ultrasonography with contrast media].
    Pennisi F; Farina R; Politi G; Lombardo R; Puleo S
    Radiol Med; 1998 Dec; 96(6):579-87. PubMed ID: 10189920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advantages and Limitations of Focal Liver Lesion Assessment with Ultrasound Contrast Agents: Comments on the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Guidelines.
    Chiorean L; Tana C; Braden B; Caraiani C; Sparchez Z; Cui XW; Baum U; Dietrich CF
    Med Princ Pract; 2016; 25(5):399-407. PubMed ID: 27318740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ultrasound contrast agents for liver diagnostics].
    Lemke AJ; Chopra SS; Niehues SM; Felix R
    Radiologe; 2005 Jun; 45(6):520-8. PubMed ID: 15912323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic imaging: techniques and unique applications of magnetic resonance imaging.
    Mitchell DG
    Magn Reson Q; 1993 Jun; 9(2):84-112. PubMed ID: 8373728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic vein transit time of an ultrasound contrast agent: simplified procedure using pulse inversion imaging.
    Bang N; Nielsen MB; Rasmussen AN; Osterhammel PA; Pedersen JF
    Br J Radiol; 2001 Aug; 74(884):752-5. PubMed ID: 11511501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.